Search by Drug Name or NDC
NDC 24385-0407-96 Calamine Phenolated Topical Suspension 10; 160 mg/mL; mg/mL Details
Calamine Phenolated Topical Suspension 10; 160 mg/mL; mg/mL
Calamine Phenolated Topical Suspension is a TOPICAL LOTION in the HUMAN OTC DRUG category. It is labeled and distributed by Amerisource Bergen. The primary component is PHENOL; ZINC OXIDE.
Product Information
| NDC | 24385-0407 |
|---|---|
| Product ID | 24385-407_0c822f72-cc76-b188-e063-6394a90a272b |
| Associated GPIs | 90971010104100 |
| GCN Sequence Number | 066316 |
| GCN Sequence Number Description | calamine/zinc oxide/phenol liq SUSPENSION 8%-8%-1% TOPICAL |
| HIC3 | L3A |
| HIC3 Description | PROTECTIVES |
| GCN | 28556 |
| HICL Sequence Number | 036957 |
| HICL Sequence Number Description | CALAMINE/ZINC OXIDE/PHENOL LIQUID |
| Brand/Generic | Generic |
| Proprietary Name | Calamine Phenolated Topical Suspension |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Calamine and Zinc Oxide and Phenol |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LOTION |
| Route | TOPICAL |
| Active Ingredient Strength | 10; 160 |
| Active Ingredient Units | mg/mL; mg/mL |
| Substance Name | PHENOL; ZINC OXIDE |
| Labeler Name | Amerisource Bergen |
| Pharmaceutical Class | Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M016 |
| Listing Certified Through | n/a |
Package
NDC 24385-0407-96 (24385040796)
| NDC Package Code | 24385-407-96 |
|---|---|
| Billing NDC | 24385040796 |
| Package | 177 mL in 1 BOTTLE, PLASTIC (24385-407-96) |
| Marketing Start Date | 2017-11-16 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.01356 |
| Pricing Unit | ML |
| Effective Date | 2021-10-20 |
| NDC Description | CALAMINE SUSPENSION |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | G |
| As of Date | 2022-10-12 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis